157 related articles for article (PubMed ID: 34598007)
21. Diagnostic accuracy of technetium-99m-pertechnetate scintigraphy with lemon juice stimulation to evaluate Warthin's tumor.
Murata Y; Yamada I; Umehara I; Okada N; Shibuya H
J Nucl Med; 1998 Jan; 39(1):43-6. PubMed ID: 9443737
[TBL] [Abstract][Full Text] [Related]
22. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors.
Razek AAKA
Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of heavily T(2) weighted magnetic resonance images for the differential diagnosis of parotid tumours.
Sakamoto M; Sasano T; Higano S; Takahashi S; Iikubo M; Kakehata S
Dentomaxillofac Radiol; 2003 Sep; 32(5):295-9. PubMed ID: 14709603
[TBL] [Abstract][Full Text] [Related]
24. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
[TBL] [Abstract][Full Text] [Related]
25. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
26. [Value of manifestations of magnetic resonance imaging (MRI) in diagnosis of parotid tumors and their pathological bases].
Yuan JP; Liang BL; Xie BK; Song ZC; Zhong JL
Ai Zheng; 2003 May; 22(5):514-9. PubMed ID: 12753715
[TBL] [Abstract][Full Text] [Related]
27. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
[TBL] [Abstract][Full Text] [Related]
28. Pleomorphic adenoma and adenolymphoma in ultrasonography.
Zajkowski P; Jakubowski W; Białek EJ; Wysocki M; Osmólski A; Serafin-Król M
Eur J Ultrasound; 2000 Sep; 12(1):23-9. PubMed ID: 10996767
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?
Tartaglione T; Botto A; Sciandra M; Gaudino S; Danieli L; Parrilla C; Paludetti G; Colosimo C
Acta Otorhinolaryngol Ital; 2015 Oct; 35(5):314-20. PubMed ID: 26824912
[TBL] [Abstract][Full Text] [Related]
30. Gray scale and Doppler ultrasonography of the benign tumors of parotid gland (pleomorphic adenoma and Warthin's tumor). Pictorial essay.
Fodor D; Pop S; Maniu A; Cosgaria M
Med Ultrason; 2010 Sep; 12(3):238-44. PubMed ID: 21203603
[TBL] [Abstract][Full Text] [Related]
31. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
32. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
33. Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands.
Hisatomi M; Asaumi J; Konouchi H; Yanagi Y; Matsuzaki H; Kishi K
Oral Oncol; 2002 Jun; 38(4):369-72. PubMed ID: 12076701
[TBL] [Abstract][Full Text] [Related]
34. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
35. MRI criteria for the diagnosis of pleomorphic adenoma: a validation study.
Zaghi S; Hendizadeh L; Hung T; Farahvar S; Abemayor E; Sepahdari AR
Am J Otolaryngol; 2014; 35(6):713-8. PubMed ID: 25128908
[TBL] [Abstract][Full Text] [Related]
36. Bilateral and multifocal Warthin's tumors of parotid glands: PET/CT imaging.
Nguyen VX; Nguyen BD; Ram PC
Clin Nucl Med; 2012 Feb; 37(2):175-7. PubMed ID: 22228345
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of an MRI-based radiomics nomogram for distinguishing Warthin's tumour from pleomorphic adenomas of the parotid gland.
Zheng YM; Chen J; Xu Q; Zhao WH; Wang XF; Yuan MG; Liu ZJ; Wu ZJ; Dong C
Dentomaxillofac Radiol; 2021 Oct; 50(7):20210023. PubMed ID: 33950705
[TBL] [Abstract][Full Text] [Related]
38. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
[TBL] [Abstract][Full Text] [Related]
39. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
[TBL] [Abstract][Full Text] [Related]
40. Characterization of parotid gland tumors using diffusion-relaxation correlation spectrum imaging: a preliminary study.
Chen W; Geng D; Xu XQ; Hu WT; Dai YM; Wu FY; Zhu LN
Clin Radiol; 2024 Jun; 79(6):e878-e884. PubMed ID: 38582630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
